secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2023-02-13T23:59:59+00:00
Accession:  0001193125-23-034187
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health reaffirms 2022 guidance, plans $425M Term Loan B to fund $408M EO litigation settlement
--------------------------------------------------------------------------------

- Reaffirms 2022 net revenue guidance of $995M-$1.005B and Adjusted EBITDA of $500M-$510M.
- Expects 2022 net loss of $226M-$236M including a $408M legal reserve for ethylene oxide settlement.
- Plans $425M Term Loan B facility to fund $408M EO settlement, pay down revolver, and boost liquidity.
- Preliminary estimates subject to completion of year-end closing; final results expected February 28, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000119312523034187/0001193125-23-034187-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000119312523034187/d428886d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-034187

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer